Business Context and Reporting Period
Company: Faraday Future Intelligent Electric Inc. (FFIE)
Filing Type: Form 8-K (Current Report)
Date of Report: February 3, 2023
Event: Entry into Amendment No. 6 to the Securities Purchase Agreement (SPA) with existing purchasers, including Senyun International Ltd. and FF Simplicity Ventures LLC.
Key Financial Metrics and Capital Structure
This filing details a financing amendment rather than reporting operational financial results (revenue, profit, or cash flow). Key capital structure metrics include:
- Tranche C Notes: Agreement to issue up to $135 million in senior secured convertible notes. This includes $10 million previously funded by Senyun as an advanced payment.
- Tranche C Terms: 10% per annum interest rate (or 15% if paid in stock); $1.05 base conversion price with full ratchet anti-dilution protection.
- Tranche C Warrants: Issued to purchasers with an exercise price of $1.05 per share, 33% of conversion shares, and a seven-year term.
- Replacement Notes: $31 million in aggregate principal ($21.6 million to FF Simplicity; $9.4 million to Senyun) replacing certain Tranche A Notes. Terms include a $0.8925 base conversion price and six-year interest make-whole.
- Exchange Notes: $41 million in aggregate principal ($25 million to FF Simplicity affiliates; $16 million to Senyun) issued in exchange for existing warrants. Terms include 11% interest per annum.
- Replacement Warrants: New warrants issued in exchange for existing warrants, exercisable at $0.2275 per share with full ratchet protection.
Material Changes Versus Prior Period
The filing outlines significant modifications to the existing financing framework:
- Extension of Options: The option for Tranche A Note purchasers to purchase Tranche B Notes was extended from 12 months to 24 months from the Effective Date.
- Removal of Down-Round Protection: The right for purchasers to receive additional warrant shares upon a down-round financing was removed from all warrants.
- Conversion Caps: Notes and Warrants are subject to a pro rata cap on conversion or exercise equal to 19.99% of the Company's Class A and B common stock until Nasdaq 20% Approval is received.
- Tranche B Purchase Limits: Revised schedule limiting the percentage of Tranche B Notes FF Simplicity and Senyun may purchase without prior written consent (ranging from 100% by Feb 10, 2023, down to 60% after April 21, 2023).
- Warrant Exchange: Existing warrants exercisable for approximately 474 million shares were exchanged for new warrants exercisable for approximately 90 million shares and new senior secured convertible notes.
Guidance, Outlook, Risks, and Contingencies
Outlook and Purpose: The Company states that once consummated, the Tranche C funding is expected to raise necessary funds for the start of production (SOP) of the FF 91 Futurist vehicle.
Conditions Precedent: Funding is contingent upon:
- Shareholder approval for an Authorized Share Increase (vote scheduled for February 28, 2023).
- Effectiveness of a Registration Statement for resale of underlying shares.
- Nasdaq 20% Approval.
- Delivery of warrants and notes to purchasers.
- Payment of legal fees up to $150,000 (or $300,000 for Senyun/FF Simplicity).
Risks and Contingencies:
- Bankruptcy Risk: Failure to satisfy conditions precedent or close financings could result in the Company seeking protection under the Bankruptcy Code.
- Nasdaq Compliance: Risks regarding the ability to regain and maintain compliance with Nasdaq listing requirements.
- Regulatory and Legal: Ongoing SEC investigation and other litigation involving the Company.
- Operational: Uncertainty regarding the timing of vehicle development, market acceptance, and the sufficiency of recent cost and headcount reduction actions.
Investor Verification Checklist
- Verify the outcome of the Special Meeting of Stockholders scheduled for February 28, 2023, specifically regarding the Authorized Share Increase and Nasdaq Listing Rule 5635 approval.
- Confirm the effectiveness of the Registration Statement required for the resale of shares underlying the Notes and Warrants.
- Monitor the Company's cash position and ability to meet the specific funding tranches (initial $25 million to Senyun, followed by subsequent tranches) within the stipulated timelines.
- Review the definitive proxy statement (Schedule 14A) for details on the interests of FF Top Representatives and the proposed equity line of credit with Yorkville Advisors.
- Assess the impact of the removal of down-round protection and the reduction in warrant share counts on existing investor value.